SIRT Versus cTACE for Unresectable HCC (CHANCE2506)

NARecruitingINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

January 30, 2027

Conditions

Unresectable Hepatocellular Carcinoma

Interventions

PROCEDURE

SIRT

Y-90 administered

PROCEDURE

cTACE

cTACE administered

Trial Locations (1)

RECRUITING

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors

lead

Zhongda Hospital

OTHER